169 related articles for article (PubMed ID: 27402308)
1. Rac3 regulates cell proliferation through cell cycle pathway and predicts prognosis in lung adenocarcinoma.
Wang G; Wang H; Zhang C; Liu T; Li Q; Lin X; Xie J; Liu H
Tumour Biol; 2016 Sep; 37(9):12597-12607. PubMed ID: 27402308
[TBL] [Abstract][Full Text] [Related]
2. Silencing of Rac3 inhibits proliferation and induces apoptosis of human lung cancer cells.
Liu TQ; Wang GB; Li ZJ; Tong XD; Liu HX
Asian Pac J Cancer Prev; 2015; 16(7):3061-5. PubMed ID: 25854406
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of Long Non-Coding RNA ZXF2 Promotes Lung Adenocarcinoma Progression Through c-Myc Pathway.
Yang ZT; Li Z; Wang XG; Tan T; Yi F; Zhu H; Zhao JP; Zhou XF
Cell Physiol Biochem; 2015; 35(6):2360-70. PubMed ID: 25896422
[TBL] [Abstract][Full Text] [Related]
4. MARCH9 Suppresses Lung Adenocarcinoma Progression by Downregulating ICAM-1.
Shen QM; Wang HY; Xu S
Cell Physiol Biochem; 2018; 50(1):92-107. PubMed ID: 30278450
[TBL] [Abstract][Full Text] [Related]
5. MACC1 silencing inhibits cell proliferation and induces cell apoptosis of lung adenocarcinoma cells through the β-catenin pathway.
Guo L; Ou S; Ma X; Zhang S; Lai Y
Neoplasma; 2018; 65(4):552-560. PubMed ID: 29940751
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of NMI promotes tumor growth and predicts poor prognosis in human lung adenocarcinomas.
Wang J; Zou K; Feng X; Chen M; Li C; Tang R; Xuan Y; Luo M; Chen W; Qiu H; Qin G; Li Y; Zhang C; Xiao B; Kang L; Kang T; Huang W; Yu X; Wu X; Deng W
Mol Cancer; 2017 Oct; 16(1):158. PubMed ID: 29025423
[TBL] [Abstract][Full Text] [Related]
7. NCAPG2 promotes tumour proliferation by regulating G2/M phase and associates with poor prognosis in lung adenocarcinoma.
Zhan P; Xi GM; Zhang B; Wu Y; Liu HB; Liu YF; Xu WJ; Zhu Q; Cai F; Zhou ZJ; Miu YY; Wang XX; Jin JJ; Li Q; Lv TF; Song Y
J Cell Mol Med; 2017 Apr; 21(4):665-676. PubMed ID: 27862966
[TBL] [Abstract][Full Text] [Related]
8. Increased KIF15 Expression Predicts a Poor Prognosis in Patients with Lung Adenocarcinoma.
Qiao Y; Chen J; Ma C; Liu Y; Li P; Wang Y; Hou L; Liu Z
Cell Physiol Biochem; 2018; 51(1):1-10. PubMed ID: 30439711
[TBL] [Abstract][Full Text] [Related]
9. YBX1 regulates tumor growth via CDC25a pathway in human lung adenocarcinoma.
Zhao S; Wang Y; Guo T; Yu W; Li J; Tang Z; Yu Z; Zhao L; Zhang Y; Wang Z; Wang P; Li Y; Li F; Sun Z; Xuan Y; Tang R; Deng WG; Guo W; Gu C
Oncotarget; 2016 Dec; 7(50):82139-82157. PubMed ID: 27384875
[TBL] [Abstract][Full Text] [Related]
10. Silencing Aurora-A with siRNA inhibits cell proliferation in human lung adenocarcinoma cells.
Zhong N; Shi S; Wang H; Wu G; Wang Y; Ma Q; Wang H; Liu Y; Wang J
Int J Oncol; 2016 Sep; 49(3):1028-38. PubMed ID: 27571708
[TBL] [Abstract][Full Text] [Related]
11. PRC1 contributes to tumorigenesis of lung adenocarcinoma in association with the Wnt/β-catenin signaling pathway.
Zhan P; Zhang B; Xi GM; Wu Y; Liu HB; Liu YF; Xu WJ; Zhu QQ; Cai F; Zhou ZJ; Miu YY; Wang XX; Jin JJ; Li Q; Qian LP; Lv TF; Song Y
Mol Cancer; 2017 Jun; 16(1):108. PubMed ID: 28646916
[TBL] [Abstract][Full Text] [Related]
12. The long non-coding RNA, GAS5, enhances gefitinib-induced cell death in innate EGFR tyrosine kinase inhibitor-resistant lung adenocarcinoma cells with wide-type EGFR via downregulation of the IGF-1R expression.
Dong S; Qu X; Li W; Zhong X; Li P; Yang S; Chen X; Shao M; Zhang L
J Hematol Oncol; 2015 Apr; 8():43. PubMed ID: 25925741
[TBL] [Abstract][Full Text] [Related]
13. HIST1H3D: A promising therapeutic target for lung cancer.
Rui Y; Peng WJ; Wang M; Wang Q; Liu ZL; Chen YQ; Huang LN
Int J Oncol; 2017 Mar; 50(3):815-822. PubMed ID: 28112369
[TBL] [Abstract][Full Text] [Related]
14. Decreased expression of RPS15A suppresses proliferation of lung cancer cells.
Zhao X; Shen L; Feng Y; Yu H; Wu X; Chang J; Shen X; Qiao J; Wang J
Tumour Biol; 2015 Sep; 36(9):6733-40. PubMed ID: 25833696
[TBL] [Abstract][Full Text] [Related]
15. Rac3 Regulates Cell Invasion, Migration and EMT in Lung Adenocarcinoma through p38 MAPK Pathway.
Zhang C; Liu T; Wang G; Wang H; Che X; Gao X; Liu H
J Cancer; 2017; 8(13):2511-2522. PubMed ID: 28900489
[No Abstract] [Full Text] [Related]
16. Induction of microRNA‑let‑7a inhibits lung adenocarcinoma cell growth by regulating cyclin D1.
Zhao W; Hu JX; Hao RM; Zhang Q; Guo JQ; Li YJ; Xie N; Liu LY; Wang PY; Zhang C; Xie SY
Oncol Rep; 2018 Oct; 40(4):1843-1854. PubMed ID: 30066899
[TBL] [Abstract][Full Text] [Related]
17. β-Catenin Cooperates with CREB Binding Protein to Promote the Growth of Tumor Cells.
Yu W; Li L; Zheng F; Yang W; Zhao S; Tian C; Yin W; Chen Y; Guo W; Zou L; Deng W
Cell Physiol Biochem; 2017; 44(2):467-478. PubMed ID: 29141249
[TBL] [Abstract][Full Text] [Related]
18. C-Myc participates in β-catenin-mediated drug resistance in A549/DDP lung adenocarcinoma cells.
Xie C; Pan Y; Hao F; Gao Y; Liu Z; Zhang X; Xie L; Jiang G; Li Q; Wang E
APMIS; 2014 Dec; 122(12):1251-8. PubMed ID: 25131138
[TBL] [Abstract][Full Text] [Related]
19. The prognostic significance of N-myc downregulated gene 1 in lung adenocarcinoma.
Dai T; Dai Y; Murata Y; Husni RE; Nakano N; Sakashita S; Noguchi M
Pathol Int; 2018 Apr; 68(4):224-231. PubMed ID: 29431240
[TBL] [Abstract][Full Text] [Related]
20. MID1-PP2A complex functions as new insights in human lung adenocarcinoma.
Zhang L; Li J; Lv X; Guo T; Li W; Zhang J
J Cancer Res Clin Oncol; 2018 May; 144(5):855-864. PubMed ID: 29450633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
